Centers for Medicare & Medicaid Services Publishes Guidance for Drug Price Negotiation Program
November 27, 2025
November 27, 2025
WASHINGTON, Nov. 27 (TNSFR) -- The U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services announced the availability of its final guidance for the third cycle of the Medicare Drug Price Negotiation Program.
This guidance addresses the first cycle of renegotiation and the requirements for manufacturers to implement the maximum fair price (MFP) in 2026, 2027, and 2028.
The negotiation program was created by the Inflation Reduction Act (IRA . . .
This guidance addresses the first cycle of renegotiation and the requirements for manufacturers to implement the maximum fair price (MFP) in 2026, 2027, and 2028.
The negotiation program was created by the Inflation Reduction Act (IRA . . .